Radiation retinopathy: a review
- 29 July 2026
- journal article
- review article
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1) , 315
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Two-year results for ranibizumab for radiation retinopathy (RRR): a randomized, prospective trialGraefe's Archive for Clinical and Experimental Ophthalmology, 2021
- Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal MelanomaJAMA Ophthalmology, 2020
- Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanomaGraefe's Archive for Clinical and Experimental Ophthalmology, 2016
- Anti–Vascular Endothelial Growth Factor Bevacizumab (Avastin) for Radiation RetinopathyArchives of Ophthalmology (1950), 2007
- The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma, III: Initial Mortality FindingsArchives of Ophthalmology (1950), 2001
- Plaque Radiotherapy for Uveal MelanomaLong-term Visual Outcome in 1106 Consecutive PatientsArchives of Ophthalmology (1950), 2000
- Proliferative Radiation RetinopathyArchives of Ophthalmology (1950), 1996
- Radiation retinopathy after external-beam irradiation: analysis of time-dose factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Improved Visualization of the Choroidal Circulation With Indocyanine Green AngiographyArchives of Ophthalmology (1950), 1993
- Photocoagulation Treatment of Radiation RetinopathyAmerican Journal of Ophthalmology, 1988